Drug maker Actavis UK broke the competition law by raising the price of tablets used for hormone replacement therapy by more than 12,000%, the UK's competition watchdog said in a ruling on Friday. The 10 mg tablets which cost the UK's National Health Service 70 pence (around ₹60) each in 2008, cost £88 (over ₹7,400) by 2016, it stated.